Innate Immunotherapeutics Limited is a medical biotechnology company with offices in Sydney Australia and Auckland New Zealand . The Company has designed and manufactured a unique immunomodulator microparticle technology. This technology can be used to induce the human immune system to fight certain cancers and infections, or modulate certain immune mechanisms implicated in autoimmune diseases such as Multiple Sclerosis. The same technology can be used in the design of better vaccines to potentially treat or prevent diseases such as influenza, cancer, malaria, or tuberculosis.
Quote | Amplia Therapeutics Ltd (OTCMKTS:INNMF)
Last: | $0.0479 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0479 |
Close: | $0.0479 |
High: | $0.0479 |
Low: | $0.0479 |
Volume: | 15,000 |
Last Trade Date Time: | 07/16/2024 03:00:00 am |
News | Amplia Therapeutics Ltd (OTCMKTS:INNMF)
(NewsDirect) Amplia Therapeutics Ltd (ASX:ATX) CEO Chris Burns joins Proactive’s Jonathan Jackson to discuss the company’s busy quarter and what investors can expect over the coming months. Burns talks us through the completion of the Phase1B stage of the ACCENT clinical trial i...
(NewsDirect) Amplia Therapeutics Ltd (ASX:ATX) CEO Dr Chris Burns tells Proactive the company has received grant funding to undertake a research collaboration with Australia’s national science agency to develop topical formulations of its FAK inhibitors. Amplia will work with resea...
Message Board Posts | Amplia Therapeutics Ltd (OTCMKTS:INNMF)
Subject | By | Source | When |
---|---|---|---|
Renee Thank you. | Echo20 | investorshub | 10/09/2018 8:23:47 PM |
Since Amplia Therapeutics Ltd. is not registered with | Renee | investorshub | 10/09/2018 7:00:48 PM |
Amiran Do post when you know. Echo20 | Echo20 | investorshub | 10/09/2018 6:25:58 PM |
Renee Do you have the total share count? Echo20 | Echo20 | investorshub | 10/09/2018 6:24:18 PM |
Innate Immunotherapeutics Ltd. changed to Amplia Therapeutics Ltd.: | Renee | investorshub | 09/12/2018 8:43:38 PM |
News, Short Squeeze, Breakout and More Instantly...
Amplia Therapeutics Ltd Company Name:
INNMF Stock Symbol:
OTCMKTS Market:
(NewsDirect) Amplia Therapeutics Ltd (ASX:ATX) CEO Chris Burns joins Proactive’s Jonathan Jackson to discuss the company’s busy quarter and what investors can expect over the coming months. Burns talks us through the completion of the Phase1B stage of the ACCENT clinical trial i...
(NewsDirect) Amplia Therapeutics Ltd (ASX:ATX) CEO Dr Chris Burns tells Proactive the company has received grant funding to undertake a research collaboration with Australia’s national science agency to develop topical formulations of its FAK inhibitors. Amplia will work with resea...
(NewsDirect) Amplia Therapeutics Ltd (ASX:ATX) CEO Dr Chris Burns speaks with Proactive following his move into the leadership role late last year. Amplia is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. FAK is an ...